In patients with anti-LGI1/CASPR2-encephalitis, treatment studies should focus on specific symptoms, e.g. seizures and cognition (7, 17), or use more distinctive clinical scores like the Clinical Assessment Scale in Autoimmune Encephalitis (CASE) (18). Here, LGI1 is linked to viral encephalitis.